Bayer is suing insurance giant AIG, alleging decades-old insurance policies should have helped cover billions of dollars in legal costs from Roundup and PCB cases now being shouldered by the German ...

Bayer’s Aspirina, the #1 pain relief option in Mexico per Bayer, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. Bayer noted that as the ...

Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals, a development that also helped a rival creating a competing drug. Bayer didn’t ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

Bayer shares rose on Monday after the company said a late-stage trial of a stroke drug met its goals. Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug ...

A Bayer drug designed to target tumors driven by a rare genetic mutation now has accelerated FDA approval, providing another treatment option for certain patients with advanced cases of lung cancer.

Bayer AG BAYRY reported third-quarter 2025 core earnings of 17 cents per American Depositary Receipt (ADR), which comfortably beat the Zacks Consensus Estimate of 13 cents per ADR. The company ...

Bayer BAYN0.56%increase; green up pointing triangle reported a net loss for the third quarter due to litigation charges, though adjusted earnings rose, and said it aims to significantly contain risks ...

Bayer is scheduled to report results for the third quarter on Wednesday. Here is what you need to know. SALES FORECAST: The German pharmaceutical and agricultural group is expected to post ...

Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of Lynkuet. The Food and Drug Administration approved the drug — also known by ...

For months now, Bayer has been hinting, then openly threatening, to pull its signature product Roundup from the market altogether in response to the tsunami of lawsuits alleging its key ingredient, ...